[Cardiac gene therapy].
Aikawa
R
R
Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine.
Komuro
I
I
Nagai
R
R
D000256:Adenoviridae; D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics; D006332:Cardiomegaly / Q000628:therapy; D009202:Cardiomyopathies / Q000628:therapy*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D006333:Heart Failure / Q000628:therapy; D000072576:Homeobox Protein Nkx-2.5; D018398:Homeodomain Proteins / Q000235:genetics; D006801:Humans; D017570:MyoD Protein / Q000235:genetics; D017202:Myocardial Ischemia / Q000628:therapy; D014157:Transcription Factors / Q000235:genetics; D016212:Transforming Growth Factor beta
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D000072576:Homeobox Protein Nkx-2.5; D018398:Homeodomain Proteins; D017570:MyoD Protein; C095552:NKX2-5 protein, human; D014157:Transcription Factors; D016212:Transforming Growth Factor beta